Xenetic Biosciences, Inc. (XBIO) Return on Sales by Net Profit

XBIO (xeneticbio.com) - company brandmark

Xenetic Biosciences (XBIO) automates the creation of oncology drugs through robotic small-molecule screening. The net profit margin illustrates management efficiency, where the -123.70 mark reflects the latest data. The asset remains independent of macroeconomic trends, as demand for treatment is constant. Currently, Xenetic Biosciences is focusing on R&D, developing the XCART platform for B-cell lymphoma therapy.

xeneticbio.com (XBIO) - Company Sales Margin from 07/04/2022 to 11/20/2026

xeneticbio.com (XBIO) - metric breakdowns and financial figures

- share price and expert price forecast:
Fundamental valuation:Xenetic Biosciences, Inc. - XBIO
Finished products of Xenetic Biosciences

A defensive portfolio requires rigorous screening of an asset's ability to generate a net residual from every dollar of revenue. This metric measures the share of final profit within total turnover, determining the business's actual margin of safety. For Xenetic Biosciences (XBIO), at the preclinical research stage of DNase, this metric reflects the efficiency of R&D cost management. The trend in net turnover profitability allows for an assessment of the company's financial stability within the laboratory cycle.

Competitors of Xenetic Biosciences (XBIO)

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|Return on Sales by Net Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Net Sales Margin|Net Return on Sales SBFM (Sunshine Biopharma)|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)